BASi Names Philip A. Downing Senior Vice President of Preclinical Services

14:12 EST 8 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced that Philip A. Downing has been promoted to Senior Vice President, Preclinical Services. This Smart News Release features multimedia. Vie...

Other Sources for this Article

Bioanalytical Systems, Inc.
Jill Blumhoff, 765-497-8381
Chief Financial Officer & Vice President of Finance


More From BioPortfolio on "BASi Names Philip A. Downing Senior Vice President of Preclinical Services"

Quick Search


Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...